Abstract: The invention pertains to methods for using chimeric polypeptides of the formula: B—X wherein B represents the B fragment of Shiga toxin or a functional equivalent thereof, and X represents one or more polypeptides of therapeutic significance. Compositions for therapeutic use comprising the polypeptide B—X are also included.
Type:
Grant
Filed:
May 21, 2003
Date of Patent:
February 10, 2009
Assignees:
Insem-Transfert, Universite Pierre Et Marie Curie (UPMC)